Author:
Good Andrew C.,Richards W.Graham
Reference85 articles.
1. Cramer, R.D. III, DePriest, S.A., Patterson DE. and Hecht, P., The developing practice of comparative Molecular Field Analysis, In 3D QSAR in drug design. Kubinyi, H. (Ed.) ESCOM, Leiden, 1993, pp. 443–485.
2. Martin. Y.C., Bures, M.G., Danaher, EA., DcLazzer, J, Lico, I. and Pavlik, P.A., A few new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists, J. Comput.-Aided Mol. Design, 7 (1993) 83–102.
3. Hopfinger, A.J., A QSAR investigation of DHFR inhibiton by Bakers Triazines based upon molecular shape analysis, J. Am. Chem. Soc., 102 (1980) 7196–7206.
4. Hopfinger, A.J., Theory and analysis of molecular potential energy fields in molecular shape analysis: A QSAR study of 2.4-diamino-5-benzylpyrimidines as DHFR inhibitors, J. Med. Chem., 26 (1983) 990–996.
5. Hermann, R.R. and Herron, D.K., OVlD and SUPER: Two over lapprograms for drug design, J. Comput.-Aided Mol. Design, 5 (1991) 511–524.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献